[Telmisartan (micardis) -- an antagonist of angiotensin 2 of type 1 receptors: another antihypertensive drug or something greater?].
作者信息
Chazova I E
出版信息
Ter Arkh. 2003;75(6):89-91.
PMID:12920969
Abstract
摘要
相似文献
1
2
Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?替米沙坦与ONTARGET试验中的卒中减少：降压之外的获益？
Cerebrovasc Dis. 2008;26(5):563-4. doi: 10.1159/000164555. Epub 2008 Oct 21.
3
ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?ONTARGET、TRANSCEND和PROFESS——澄清、混淆还是误导？
Blood Press. 2009;18(1-2):4-6. doi: 10.1080/08037050902742282.
4
Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.通过磁共振成像评估轻度至中度高血压患者的血压降低情况（TELMAR）——替米沙坦与美托洛尔在六个月期间的前瞻性、随机、双盲比较：原理与研究设计
J Renin Angiotensin Aldosterone Syst. 2003 Dec;4(4):234-43. doi: 10.3317/jraas.2003.038.
5
[Observational study of an AT1-antagonist].[一种血管紧张素Ⅱ1型受体拮抗剂的观察性研究]
MMW Fortschr Med. 2007 Aug 16;149(33-34):37. doi: 10.1007/BF03365120.
6
[In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension].在曼海姆举行的德国心脏病学会（DKG）第72届年会上展示：“目标治疗”——迄今为止关于高血压患者心血管预防的最大规模研究项目。
MMW Fortschr Med. 2006 Jun 29;148(26):50-1.
7
[Therapy of hypertension. Also pulse pressure must be reduced].
MMW Fortschr Med. 2003 Sep 11;145(37):65.
8
Prevention of stroke in patients with hypertension.高血压患者中风的预防
Am J Cardiol. 2007 Aug 6;100(3A):17J-24J. doi: 10.1016/j.amjcard.2007.05.010. Epub 2007 May 25.
9
[Therapy of hypertension with expanded outlook. Constant pressure decline and organ protection].
MMW Fortschr Med. 2007 Dec 6;149(49-50):52-3.
10
[Telmisartan].[替米沙坦]
Krankenpfl J. 2005;43(4-6):110-1.
Zotero 插件